UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.16 +0.17 (+0.22%) GOLD FUTURES
2,316.30 -6.00 (-0.26%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,014.55 -1,320.54 (-2.62%)
ACAD Sep 2024 31.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:12AM EDT. Market open.
| Previous close | 1.6000 |
| Open | 1.6000 |
| Bid | 0.0500 |
| Ask | 0.2000 |
| Strike | 31.00 |
| Expiry date | 2024-09-20 |
| Day's range | 1.6000 - 1.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 305 |
ZacksAcadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
Acadia (ACAD) delivered earnings and revenue surprises of 150% and 0.52%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Business WireAcadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
SAN DIEGO, May 08, 2024--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the first quarter ended March 31, 2024.
ZacksWatch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Let us look at five drug, generic companies, PRGO, IOVA, VTRS, TEVA and ACAD, which are gearing up for their earnings release this week.
© 2024 Yahoo. All rights reserved.